Literature DB >> 12900000

Serum levels of beta-trace protein and glomerular filtration rate--preliminary results.

Carlo Donadio1, Annalisa Lucchesi, Michela Ardini, Elena Donadio, Roberto Giordani.   

Abstract

The aim of this study was to evaluate the relationship between serum levels of beta-trace protein (BTP), a low molecular weight (MW) protein, and glomerular filtration rate (GFR). GFR and serum levels of BTP, and for comparison creatinine (Creat), cystatin C (Cys) and beta 2-microglobulin (beta 2M), were measured in 60 patients, with renal function ranging from normality to advanced renal failure. Serum levels of BTP progressively increased with the reduction of GFR. A good correlation was found between GFR and serum levels of BTP (r=0.918), Creat (r=0.932), Cys (r=0.937), and beta 2M (r=0.924). Furthermore, no statistically significant difference was found between BTP and Creat, Cys, beta 2M, as indicators of a moderate GFR impairment. These preliminary data indicate that BTP might be suitable as an indicator of GFR.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12900000     DOI: 10.1016/s0731-7085(03)00215-2

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  11 in total

1.  Filtration markers may have prognostic value independent of glomerular filtration rate.

Authors:  Navdeep Tangri; Lesley A Inker; Hocine Tighiouart; Eric Sorensen; Vandana Menon; Gerald Beck; Michael Shlipak; Josef Coresh; Andrew S Levey; Mark J Sarnak
Journal:  J Am Soc Nephrol       Date:  2011-12-15       Impact factor: 10.121

2.  Comparison of measured GFR, serum creatinine, cystatin C, and beta-trace protein to predict ESRD in African Americans with hypertensive CKD.

Authors:  Nrupen A Bhavsar; Lawrence J Appel; John W Kusek; Gabriel Contreras; George Bakris; Josef Coresh; Brad C Astor
Journal:  Am J Kidney Dis       Date:  2011-09-22       Impact factor: 8.860

3.  β-trace protein versus cystatin C: which is a better surrogate marker of renal function versus prognostic indicator in cardiovascular diseases?

Authors:  Horng H Chen
Journal:  J Am Coll Cardiol       Date:  2011-02-15       Impact factor: 24.094

4.  Applicability of various estimation formulas to assess renal function in Chinese children.

Authors:  Yue Du; Ting-Ting Sun; Ling Hou; Jin-Jie Guo; Xiu-Li Wang; Yu-Bin Wu
Journal:  World J Pediatr       Date:  2014-12-01       Impact factor: 2.764

5.  Estimation of GFR using β-trace protein in children.

Authors:  Samantha H Witzel; Shih-Han S Huang; Branko Braam; Guido Filler
Journal:  Clin J Am Soc Nephrol       Date:  2014-12-26       Impact factor: 8.237

6.  Serum β-trace protein and risk of mortality in incident hemodialysis patients.

Authors:  Tariq Shafi; Rulan S Parekh; Bernard G Jaar; Laura C Plantinga; Pooja C Oberai; John H Eckfeldt; Andrew S Levey; Neil R Powe; Josef Coresh
Journal:  Clin J Am Soc Nephrol       Date:  2012-06-28       Impact factor: 8.237

7.  Comparison of serum concentrations of β-trace protein, β2-microglobulin, cystatin C, and creatinine in the US population.

Authors:  Stephen P Juraschek; Josef Coresh; Lesley A Inker; Andrew S Levey; Anna Köttgen; Meredith C Foster; Brad C Astor; John H Eckfeldt; Elizabeth Selvin
Journal:  Clin J Am Soc Nephrol       Date:  2013-01-18       Impact factor: 8.237

Review 8.  Rediscovering Beta-2 Microglobulin As a Biomarker across the Spectrum of Kidney Diseases.

Authors:  Christos P Argyropoulos; Shan Shan Chen; Yue-Harn Ng; Maria-Eleni Roumelioti; Kamran Shaffi; Pooja P Singh; Antonios H Tzamaloukas
Journal:  Front Med (Lausanne)       Date:  2017-06-15

9.  β-trace protein is highly removed during haemodialysis with high-flux and super high-flux membranes.

Authors:  Carlo Donadio; Danika Tognotti; Laura Caponi; Aldo Paolicchi
Journal:  BMC Nephrol       Date:  2017-02-20       Impact factor: 2.388

10.  Urinary β-trace protein: A unique biomarker to screen early glomerular filtration rate impairment.

Authors:  Carlo Donadio; Laura Bozzoli
Journal:  Medicine (Baltimore)       Date:  2016-12       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.